Literature DB >> 26948758

Nodal metastases in thyroid cancer: prognostic implications and management.

Laura Y Wang1, Ian Ganly1.   

Abstract

The significance of cervical lymph node metastases in differentiated thyroid cancer has been controversial and continues to evolve. Current staging systems consider nodal metastases to confer a poorer prognosis, particularly in older patients. Increasingly, the literature suggests that characteristics of the metastatic lymph nodes such as size and number are also prognostic. There is a growing trend toward less aggressive treatment of low-volume nodal disease. The aim of this review is to summarize the current literature and discuss prognostic and management implications of lymph node metastases in differentiated thyroid cancer.

Entities:  

Keywords:  lymph nodes; neck; neck dissection; outcomes; prognosis; radioactive iodine; recurrence; survival; thyroid cancer

Mesh:

Substances:

Year:  2016        PMID: 26948758      PMCID: PMC4992997          DOI: 10.2217/fon.16.10

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  90 in total

1.  The pattern of metastasis of carcinoma of the thyroid.

Authors:  G CRILE
Journal:  Ann Surg       Date:  1956-05       Impact factor: 12.969

2.  In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.

Authors:  Mauricio A Moreno; Beth S Edeiken-Monroe; Eric R Siegel; Steven I Sherman; Gary L Clayman
Journal:  Thyroid       Date:  2012-01-26       Impact factor: 6.568

3.  Preoperative neck ultrasound in clinical node-negative differentiated thyroid cancer.

Authors:  Laura Y Wang; Frank L Palmer; Dorothy Thomas; Ashok R Shaha; Jatin P Shah; Snehal G Patel; R Michael Tuttle; Ian Ganly
Journal:  J Clin Endocrinol Metab       Date:  2014-07-25       Impact factor: 5.958

4.  Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer.

Authors:  Laura Y Wang; Frank L Palmer; Iain J Nixon; Dorothy Thomas; Jatin P Shah; Snehal G Patel; R Michael Tuttle; Ashok R Shaha; Ian Ganly
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

5.  Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

6.  Localization of cervical node metastasis of papillary thyroid carcinoma.

Authors:  E Mirallié; J Visset; C Sagan; A Hamy; M F Le Bodic; J Paineau
Journal:  World J Surg       Date:  1999-09       Impact factor: 3.352

7.  Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.

Authors:  Mark Sywak; Lachlan Cornford; Paul Roach; Peter Stalberg; Stan Sidhu; Leigh Delbridge
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

8.  Evaluating the morbidity and efficacy of reoperative surgery in the central compartment for persistent/recurrent papillary thyroid carcinoma.

Authors:  Brian Hung-Hin Lang; George C C Lee; Cathy P C Ng; Kai Pun Wong; Koon Yat Wan; Chung-Yau Lo
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

Review 9.  Thyroid cancer nodal metastases: biologic significance and therapeutic considerations.

Authors:  S K Grebe; I D Hay
Journal:  Surg Oncol Clin N Am       Date:  1996-01       Impact factor: 3.495

10.  Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Mitsuyoshi Hirokawa; Tomoo Jikuzono; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

View more
  18 in total

Review 1.  Total thyroidectomy versus thyroid lobectomy in the treatment of papillary carcinoma.

Authors:  Marco Raffaelli; Serena Elisa Tempera; Luca Sessa; Celestino Pio Lombardi; Carmela De Crea; Rocco Bellantone
Journal:  Gland Surg       Date:  2020-01

2.  Frozen section analysis of central lymph nodes in papillary thyroid cancer: the significance in determining the extent of surgery.

Authors:  Min Jhi Kim; Hee Jun Kim; Cheong Soo Park; Bup-Woo Kim
Journal:  Gland Surg       Date:  2022-04

3.  Identification of soluble tissue-derived biomarkers from human thyroid tissue explants maintained on a microfluidic device.

Authors:  Andrew Riley; Heidi Jones; James England; Dmitriy Kuvshinov; Victoria Green; John Greenman
Journal:  Oncol Lett       Date:  2021-09-13       Impact factor: 2.967

4.  Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid Carcinogenesis.

Authors:  Sandya Liyanarachchi; Wei Li; Pearlly Yan; Ralf Bundschuh; Pamela Brock; Leigha Senter; Matthew D Ringel; Albert de la Chapelle; Huiling He
Journal:  J Clin Endocrinol Metab       Date:  2016-07-26       Impact factor: 5.958

5.  miR-3619-3p promotes papillary thyroid carcinoma progression via Wnt/β-catenin pathway.

Authors:  Shuang Yu; Siting Cao; Shubin Hong; Xiaorong Lin; Hongyu Guan; Shuwei Chen; Quan Zhang; Weiming Lv; Yanbing Li; Haipeng Xiao
Journal:  Ann Transl Med       Date:  2019-11

6.  Prophylactic Central Neck Dissection in Papillary Thyroid Carcinoma: All Risks, No Reward.

Authors:  Jonathan Dismukes; Jessica Fazendin; Ruth Obiarinze; Gianina C Hernández Márquez; Kimberly M Ramonell; Erin Buczek; Brenessa Lindeman; Herbert Chen
Journal:  J Surg Res       Date:  2021-04-08       Impact factor: 2.417

7.  Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery.

Authors:  Liwei Jiang; Sungwook Jung; Jing Zhao; Vivek Kasinath; Takaharu Ichimura; John Joseph; Paolo Fiorina; Andrew S Liss; Khalid Shah; Nasim Annabi; Nitin Joshi; Tomoya O Akama; Jonathan S Bromberg; Motohiro Kobayashi; Kenji Uchimura; Reza Abdi
Journal:  Nano Today       Date:  2020-12-14       Impact factor: 20.722

8.  Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.

Authors:  Hye In Kim; Tae Hyuk Kim; Jun-Ho Choe; Jung-Han Kim; Jee Soo Kim; Young Lyun Oh; Soo Yeon Hahn; Jung Hee Shin; Hye Won Jang; Young Nam Kim; Hosu Kim; Hyeon Seon Ahn; Kyunga Kim; Sun Wook Kim; Jae Hoon Chung
Journal:  Cancer Med       Date:  2017-08-31       Impact factor: 4.452

9.  Upregulation of sphingosine kinase 1 is associated with recurrence and poor prognosis in papillary thyroid carcinoma.

Authors:  Jie Li; Bo Zhang; Yang Bai; Yonghong Liu; Buyong Zhang; Jian Jin
Journal:  Oncol Lett       Date:  2019-09-24       Impact factor: 2.967

10.  Ultrasonography for the Prediction of High-Volume Lymph Node Metastases in Papillary Thyroid Carcinoma: Should Surgeons Believe Ultrasound Results?

Authors:  Chunhao Liu; Lei Zhang; Yuewu Liu; Yu Xia; Yue Cao; Ziwen Liu; Ge Chen; Ning Liu; Zhonghua Shang; Jinbao Yang; Qinghe Sun; Xiaoyi Li
Journal:  World J Surg       Date:  2020-09-11       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.